840 related articles for article (PubMed ID: 31202925)
1. Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
Lee YL; Lu MC; Shao PL; Lu PL; Chen YH; Cheng SH; Ko WC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Lee WS; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Liao MH; Hsueh PR
Int J Antimicrob Agents; 2019 Sep; 54(3):318-328. PubMed ID: 31202925
[TBL] [Abstract][Full Text] [Related]
2. The distribution of carbapenem- and colistin-resistance in Gram-negative bacteria from the Tamil Nadu region in India.
Manohar P; Shanthini T; Ayyanar R; Bozdogan B; Wilson A; Tamhankar AJ; Nachimuthu R; Lopes BS
J Med Microbiol; 2017 Jul; 66(7):874-883. PubMed ID: 28671537
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of ceftazidime-avibactam, ceftolozane-tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).
Jean SS; Lu MC; Shi ZY; Tseng SH; Wu TS; Lu PL; Shao PL; Ko WC; Wang FD; Hsueh PR
Infect Drug Resist; 2018; 11():1983-1992. PubMed ID: 30464540
[TBL] [Abstract][Full Text] [Related]
4. Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009.
Jean SS; Hsueh PR; Lee WS; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Lam C; Chen RJ
Int J Antimicrob Agents; 2013 May; 41(5):457-62. PubMed ID: 23507415
[TBL] [Abstract][Full Text] [Related]
5. Detection of diverse carbapenem and multidrug resistance genes and high-risk strain types among carbapenem non-susceptible clinical isolates of target gram-negative bacteria in Kenya.
Musila L; Kyany'a C; Maybank R; Stam J; Oundo V; Sang W
PLoS One; 2021; 16(2):e0246937. PubMed ID: 33617559
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of metallo-β-lactamase acquired genes among carbapenems susceptible and resistant Gram-negative clinical isolates using multiplex PCR, Khartoum hospitals, Khartoum Sudan.
Adam MA; Elhag WI
BMC Infect Dis; 2018 Dec; 18(1):668. PubMed ID: 30558551
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance phenotypes and genotypes in Mexico in representative gram-negative species: Results from the infivar network.
Garza-González E; Bocanegra-Ibarias P; Bobadilla-Del-Valle M; Ponce-de-León-Garduño LA; Esteban-Kenel V; Silva-Sánchez J; Garza-Ramos U; Barrios-Camacho H; López-Jácome LE; Colin-Castro CA; Franco-Cendejas R; Flores-Treviño S; Morfín-Otero R; Rojas-Larios F; Mena-Ramírez JP; Fong-Camargo MG; Morales-De-la-Peña CT; García-Mendoza L; Choy-Chang EV; Aviles-Benitez LK; Feliciano-Guzmán JM; López-Gutiérrez E; Gil-Veloz M; Barajas-Magallón JM; Aguirre-Burciaga E; López-Moreno LI; Martínez-Villarreal RT; Canizales-Oviedo JL; Cetina-Umaña CM; Romero-Romero D; Bello-Pazos FD; Barlandas-Rendón NRE; Maldonado-Anicacio JY; Bolado-Martínez E; Galindo-Méndez M; Perez-Vicelis T; Alavez-Ramírez N; Méndez-Sotelo BJ; Cabriales-Zavala JF; Nava-Pacheco YC; Moreno-Méndez MI; García-Romo R; Silva-Gamiño AR; Avalos-Aguilera AM; Santiago-Calderón MA; López-García M; Velázquez-Acosta MDC; Cobos-Canul DI; Vázquez-Larios MDR; Ortiz-Porcayo AE; Guerrero-Núñez AE; Valero-Guzmán J; Rosales-García AA; Ostos-Cantú HL; Camacho-Ortiz A
PLoS One; 2021; 16(3):e0248614. PubMed ID: 33730101
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of Plasmid Mediated mcr Colistin Resistance Gene in Clinical Enterobacterales Isolates].
Özkaya E; Buruk CK; Tosun İ; Toraman B; Kaklıkkaya N; Aydın F
Mikrobiyol Bul; 2020 Apr; 54(2):191-202. PubMed ID: 32723275
[TBL] [Abstract][Full Text] [Related]
9. National Surveillance of Antimicrobial Susceptibility of Bacteremic Gram-Negative Bacteria with Emphasis on Community-Acquired Resistant Isolates: Report from the 2019 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).
Liu PY; Lee YL; Lu MC; Shao PL; Lu PL; Chen YH; Cheng SH; Ko WC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Lee WS; Chen YS; Wang FD; Tseng SH; Lin CN; Tang HJ; Chen YH; Sheng WH; Lee CM; Liao MH; Hsueh PR
Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32690650
[TBL] [Abstract][Full Text] [Related]
10. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene
Li Y; Sun QL; Shen Y; Zhang Y; Yang JW; Shu LB; Zhou HW; Wang Y; Wang B; Zhang R; Wang S; Shen Z
J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386265
[TBL] [Abstract][Full Text] [Related]
11. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
[TBL] [Abstract][Full Text] [Related]
12. Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).
Jean SS; Lee WS; Yu KW; Liao CH; Hsu CW; Chang FY; Ko WC; Chen RJ; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Lam C; Liu CY; Hsueh PR
J Microbiol Immunol Infect; 2016 Dec; 49(6):969-976. PubMed ID: 25661253
[TBL] [Abstract][Full Text] [Related]
13. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
Falagas ME; Skalidis T; Vardakas KZ; Legakis NJ;
J Antimicrob Chemother; 2017 Jun; 72(6):1704-1708. PubMed ID: 28369471
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
[TBL] [Abstract][Full Text] [Related]
15. Genetic characterisation of carbapenem-resistant Gram-negative bacteria isolated from the University Hospital Mohamed Boudiaf in Ouargla, southern Algeria.
Yagoubat M; Ould El-Hadj-Khelil A; Malki A; Bakour S; Touati A; Rolain JM
J Glob Antimicrob Resist; 2017 Mar; 8():55-59. PubMed ID: 28007519
[TBL] [Abstract][Full Text] [Related]
16. Molecular characteristics of carbapenem-resistant gram-negative bacteria in southern China.
Zheng F; Sun J; Cheng C; Rui Y
Microb Drug Resist; 2015 Apr; 21(2):178-85. PubMed ID: 25469995
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).
Lai CC; Chen YS; Lee NY; Tang HJ; Lee SS; Lin CF; Lu PL; Wu JJ; Ko WC; Lee WS; Hsueh PR
Infect Drug Resist; 2019; 12():627-640. PubMed ID: 30936726
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).
Wang Q; Wang X; Wang J; Ouyang P; Jin C; Wang R; Zhang Y; Jin L; Chen H; Wang Z; Zhang F; Cao B; Xie L; Liao K; Gu B; Yang C; Liu Z; Ma X; Jin L; Zhang X; Man S; Li W; Pei F; Xu X; Jin Y; Ji P; Wang H
Clin Infect Dis; 2018 Nov; 67(suppl_2):S196-S205. PubMed ID: 30423057
[TBL] [Abstract][Full Text] [Related]
19. Isolation of Carbapenem and Colistin Resistant Gram-Negative Bacteria Colonizing Immunocompromised SARS-CoV-2 Patients Admitted to Some Libyan Hospitals.
Slimene K; Ali AA; Mohamed EA; El Salabi A; Suliman FS; Elbadri AA; El-Fertas FF; El-Awjly A; Shokri SA; Rolain JM; Chouchani C
Microbiol Spectr; 2023 Jun; 11(3):e0297222. PubMed ID: 37042782
[TBL] [Abstract][Full Text] [Related]
20. Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP).
Mataseje LF; Bryce E; Roscoe D; Boyd DA; Embree J; Gravel D; Katz K; Kibsey P; Kuhn M; Mounchili A; Simor A; Taylor G; Thomas E; Turgeon N; Mulvey MR;
J Antimicrob Chemother; 2012 Jun; 67(6):1359-67. PubMed ID: 22398651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
